Genzyme Settles For $32.5 Million With DOJ Over Unlawful Distribution
This article was originally published in The Gray Sheet
Executive Summary
Genzyme, a subsidiary of Sanofi, agreed to settle for $32.5 million unlawful distribution charges with the Department of Justice on Sept. 3, based on allegations that Genzyme sale reps taught surgeons how to mix the firm’s Seprafilm into a liquid slurry for application in surgeries – an unapproved use.